Navigation Links
Euclid Systems Corporation signs agreement with Wenzhou Medical University to promote the use of Orthokeratology to control myopia progression
Date:9/11/2013

HERNDON, Va., Sept. 11, 2013 /PRNewswire/ -- Euclid Systems Corporation today announced the signing of a cooperation agreement with Wenzhou Medical University Eye Hospital. 

"Thanks to a number of studies showing the ability of Euclid's Emerald™ brand Ortho-K lens to retard the progression (worsening) of myopia in children, the Chinese population are accepting this treatment in increasing numbers," stated Michael A Ross, MD, President and COO of Euclid.  "This strategic partnership with the Wenzhou Medical University will further enhance Euclid's reputation as the leading provider of Ortho-K lenses in China and throughout Asia."

Through this cooperative agreement, Euclid will support and assist the University in several areas, including the training of new Optometrists and Ophthalmologists in the fitting and use of Orthokeratology lenses, as well as to study of the advantages of Orthokeratology for the prevention of the progression of myopia (nearsightedness) and for treatment for high myopes (extremely nearsighted) patients.  Wenzhou University will support Euclid by presenting at Ophthalmology meetings and conferences, by being a resource for prescribing doctors throughout China, and by promoting the health benefits and care standards for Orthokeratology.  Additionally the University will work with Euclid to open an Ortho-K Trial Center on the hospital grounds as a model for prescribing doctors in China.

About Wenzhou Medical University Eye Hospital.  The Affiliated Eye Hospital of Wenzhou Medical University is a class-A specialized eye hospital and is famous for its "Wenzhou Model" of combination of optometry and ophthalmology.  The eye hospital, the chairman unit of the Chinese Optometry Association, leads the development of optometry in China.  It is also the National Optometry Center of Ministry of Public Health P.R.China and the chairman unit of International Academy Orthokeratology Asia, playing a leading role in the training, discipline development, security monitoring and organization development of Orthokeratology in China.

About Euclid Systems Corporation.  Euclid, founded in 1995, first developed and brought to market a standardized Ortho-K lens design and manufacturing process.  Euclid was the first company to apply for FDA approval, and the Emerald lens was approved by the FDA in 2004.  The Emerald lens has obtained regulatory approval from the appropriate governing bodies in multiple international markets.  Additionally, Euclid is involved in a number of research projects investigating corneal stabilization.


'/>"/>
SOURCE Euclid Systems Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sentry Data Systems Expands Support Organization To Address Pharmacy Procurement Management And Compliance Needs
2. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
3. National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood Glucose Monitoring Systems
4. Global Endoscopy Systems Industry
5. Global Medical Laser Systems Industry
6. Global Medical Oxygen Systems Industry
7. John Ault Appointed Director of Business Development for MedTek Systems LLC
8. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
9. Varian Medical Systems Publishes 2013 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
10. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
11. WaferGen Bio-systems Announces New Funding from Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Manufacturing Market, 2017-2027" report to their offering. ... The Cell Therapy ... rapidly growing market of cell therapy manufacturing and focuses both ... facilities. These therapies are anticipated to emerge as viable alternatives ...
(Date:3/24/2017)... March 24, 2017  Zymo Research Corp., ... Hamilton Robotics, Inc., who designs, manufactures and ... collaboration that teams Zymo Research,s DNA methylation ... DNA extraction products with Hamilton,s high-throughput automation ... methods for microbiomics and RNA isolation for ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... 27, 2017 , ... Adding to its expanding portfolio of ... and NEJM Journal Watch, announces the release of NEJM Knowledge+ Pediatrics Board ... of pediatricians from leading medical centers. The content was then reviewed and approved ...
(Date:3/27/2017)... Birmingham, Clarkston, and Lake Orion, Michigan (PRWEB) , ... ... ... can affect weight loss results. The comprehensive weight management program at Women’s ... begins with an initial evaluation and physical exam. The specialists at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 ... had in a long time,” she said. , She thinks the coming week is going ... never thought I would have to help my students.” , The award will allow the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... a settlement agreement to resolve the pending litigation between itself and 1800 Vending ... District of Utah). , “I am thrilled to announce that we have now ...
(Date:3/26/2017)... (PRWEB) , ... March 26, 2017 , ... ... worldwide to receive the RealSelf 100 Award, a prestigious award honoring the top ... procedures and to find and connect with doctors and clinics. , In 2016, ...
Breaking Medicine News(10 mins):